NK/T CELL LYMPHOMA NOS

Clinical trials for NK/T CELL LYMPHOMA NOS explained in plain language.

Never miss a new study

Get alerted when new NK/T CELL LYMPHOMA NOS trials appear

Sign up with your email to follow new studies for NK/T CELL LYMPHOMA NOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo trial offers hope for aggressive blood cancer

Disease control Ongoing

This study is testing whether adding the immunotherapy drug Sintilimab to a standard chemotherapy regimen is safe and effective for people newly diagnosed with an advanced form of a rare and aggressive blood cancer called NK/T-cell lymphoma. The trial will enroll 34 adults to see…

Matched conditions: NK/T CELL LYMPHOMA NOS

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

NK/T CELL LYMPHOMA NOS

Get alerted when new NK/T CELL LYMPHOMA NOS trials appear

New drug combo trial offers hope for aggressive blood cancer